Survey Results 1 : #Perfusion2

The development of oxygen (O2)-carrying blood substitutes has evolved from the goal of replicating blood O2 transport properties to that of preserving microvascular and organ function, reducing the inherent or potential toxicity of the material used to carry O2, and treating pathologies initiated by anemia and hypoxia.

Short-term anticoagulation may be sufficient for the prevention of thromboembolic events in patients who underwent off-pump coronary artery bypass grafting and experienced new-onset AF because right and left atrial contractility was restored early after sinus conversion.